# A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.

> **NCT00154245** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 20 (—)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Enteric-Coated Mycophenolate sodium (EC-MPS)

## Key facts

- **NCT ID:** NCT00154245
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 20 (—)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154245, "A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00154245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*